Thiazolidine derivatives, process for their preparation and pharmaceutical compositions
申请人:CHIESI FARMACEUTICI S.p.A.
公开号:EP0222371A2
公开(公告)日:1987-05-20
Compounds of formula I
wherein A represents:
- a saturated or unsaturated acyclic residue;
- a saturated cyclic or heterocylic residue;
- a saturated or unsaturated bicyclic residue
and R represents OH, a C₁-C₄ alkoxy group or a straight or heterocycle aminoresidue; R₁ represents hydrogen, an alkyl group or an aromatic or heteroaromatic residue.
Compounds I are endowed with valuable therapeutic characteristics.
式 I 的化合物
其中 A 代表
- 饱和或不饱和无环残基
- 饱和环状或杂环残基
- 饱和或不饱和双环残基
和 R 代表 OH、C₁-C₄ 烷氧基或直链或杂环氨基残基;R₁ 代表氢、烷基或芳香族或杂芳族残基。
化合物 I 具有宝贵的治疗特性。